FDA inspection
Dexcom, Inc.: FDA inspection ending Feb 16, 2018
FDA inspection 1041434 · Voluntary Action Indicated (VAI) · San Diego, CA
Key facts
| Inspection ID | 1041434 |
|---|---|
| Firm | Dexcom, Inc. |
| FEI number | 3004753838 |
| Address | 6340 Sequence Dr |
| City | San Diego |
| State | CA |
| ZIP | 92121 |
| Country | United States |
| Fiscal year | 2018 |
| Inspection end date | Feb 16, 2018 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Devices |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data